H

Humedix Co Ltd
KOSDAQ:200670

Watchlist Manager
Humedix Co Ltd
KOSDAQ:200670
Watchlist
Price: 50 700 KRW -5.41% Market Closed
Market Cap: 569.4B KRW
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+19%
Revenue
Forecast
+18%
Operating Income
Forecast
+26%
Net Income
Forecast
+24%

Wall Street
Price Targets

Price Targets Summary
Humedix Co Ltd

Wall Street analysts forecast Humedix Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Humedix Co Ltd is 60 520 KRW with a low forecast of 53 530 KRW and a high forecast of 66 150 KRW.

Lowest Forecast
Wall Street Target
53 530 KRW
6% Upside
Average Forecast
Wall Street Target
60 520 KRW
19% Upside
Highest Forecast
Wall Street Target
66 150 KRW
30% Upside
Lowest
Price Target
53 530 KRW
6% Upside
Average
Price Target
60 520 KRW
19% Upside
Highest
Price Target
66 150 KRW
30% Upside
Humedix Co Ltd Competitors:
Price Targets
KLBF
Kalbe Farma Tbk PT
6% Upside
4554
Fuji Pharma Co Ltd
70% Upside
FULC
Fulcrum Therapeutics Inc
7% Upside
C
CLN
Celon Pharma SA
27% Upside
KLBF
Kalbe Farma Tbk PT
6% Upside
4554
Fuji Pharma Co Ltd
70% Upside
FULC
Fulcrum Therapeutics Inc
7% Upside
C
CLN
Celon Pharma SA
27% Upside
600572
Zhejiang CONBA Pharmaceutical Co Ltd
64% Upside
MEDCL
Medincell SA
41% Upside
4886
ASKA Pharmaceutical Holdings Co Ltd
13% Upside
MRK
Merck KGaA
43% Upside

Revenue
Forecast

Revenue Estimate
Humedix Co Ltd

For the last 11 years the compound annual growth rate for Humedix Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 18%.

19%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Humedix Co Ltd

For the last 11 years the compound annual growth rate for Humedix Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 26%.

17%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Humedix Co Ltd

For the last 11 years the compound annual growth rate for Humedix Co Ltd's net income is 14%. The projected CAGR for the next 3 years is 24%.

14%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-18%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Humedix Co Ltd's stock price target?
Price Target
60 520 KRW

According to Wall Street analysts, the average 1-year price target for Humedix Co Ltd is 60 520 KRW with a low forecast of 53 530 KRW and a high forecast of 66 150 KRW.

What is Humedix Co Ltd's Revenue forecast?
Projected CAGR
18%

For the last 11 years the compound annual growth rate for Humedix Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 18%.

What is Humedix Co Ltd's Operating Income forecast?
Projected CAGR
26%

For the last 11 years the compound annual growth rate for Humedix Co Ltd's operating income is 17%. The projected CAGR for the next 3 years is 26%.

What is Humedix Co Ltd's Net Income forecast?
Projected CAGR
24%

For the last 11 years the compound annual growth rate for Humedix Co Ltd's net income is 14%. The projected CAGR for the next 3 years is 24%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 260,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.